Epilepsy Overview
Epilepsy Overview
Epilepsy is an enduring tendency to have seizures that are provoked by nothing. A seizure is the event itself: a brief burst of abnormal electrical activity in the brain that changes awareness, movement, sensation or behaviour for seconds to minutes before it stops on its own. The two are not the same thing, and keeping them apart is what most of this page is for. One seizure is not epilepsy, and neither is a seizure brought on by fever, low blood sugar, alcohol withdrawal or the first week after a head injury. What makes epilepsy is recurrence without a temporary cause.
-
National
Stroke Center construction unit, and a national GCP base
-
Video EEG
Long-term monitoring alongside 3.0T MRI, PET-CT and 3D DSA
-
48 hours
Written second-opinion report after complete records arrive
-
124+
Countries and regions our international patients come from
What a seizure is, and what epilepsy is
A seizure happens when a group of nerve cells in the brain fires in an abnormal, synchronised burst. It starts suddenly, it runs a course that is characteristic of where it began, and it stops by itself, usually within two minutes. What the person experiences depends entirely on which part of the brain is involved: a seizure in the motor strip produces jerking, one in the temporal lobe produces a smell or a memory that was never there, one in the occipital lobe produces flashes of light, and one that involves both hemispheres from the start produces loss of consciousness.
Epilepsy is not the seizure. It is the tendency to have seizures that no temporary cause explains, and it is diagnosed when that tendency is expected to continue. In practice the diagnosis rests on one of three: at least two unprovoked seizures more than 24 hours apart; one unprovoked seizure together with a risk of recurrence high enough to treat; or a recognised epilepsy syndrome. This is a definition about probability, and it exists because a single seizure in a person with a normal brain, a normal examination and a normal scan recurs less often than not.
The contrast that matters clinically is with provoked seizures, also called acute symptomatic seizures. A convulsion during a high fever in a toddler, a seizure during an episode of severe hypoglycaemia, a withdrawal seizure in someone stopping alcohol after years of heavy use, a seizure in the first week after a head injury or a stroke — all of these have a temporary cause that can be named, and none of them alone means the person has epilepsy. Treating them as epilepsy puts someone on daily medication for years for an event that had an explanation.
Two further things keep this honest. The diagnosis is clinical: it is made from the history, and the investigations support it rather than establish it. An EEG is often normal in someone who unquestionably has epilepsy, because it samples a few minutes of a brain that misbehaves occasionally; and a small proportion of people without epilepsy have epileptiform activity on it.
Where seizures begin, and which syndrome
Two questions are asked, in this order, and they are not the same question. The first is where the seizure begins in the brain, which decides the medication. The second is which epilepsy syndrome this is, which decides the outlook, the likelihood of remission, and how long treatment will be needed.
Focal onset. The seizure starts in one region of one hemisphere. If awareness is preserved throughout, the person watches it happen and can describe it afterwards; the jerking of one hand, the tingling that climbs an arm, the smell that no one else can smell, the sudden dread, or the sensation of having lived this moment before. If awareness is impaired, the person stares, stops responding, and performs automatic movements — lip-smacking, picking at clothing, fumbling, walking without purpose — with no memory of it and with a period of confusion afterwards. A focal seizure can also spread to involve both hemispheres, which is what produces the convulsion that gets described to a doctor; the beginning of the event, not the end of it, is what classifies it.
Generalised onset. The seizure engages both hemispheres from the first moment. It includes absence seizures — a blank stare with unresponsiveness lasting seconds, dozens of times a day, in a child who resumes the sentence they were in the middle of; myoclonic jerks, brief and shock-like, clustered in the first hour after waking and often first noticed as spilled drinks and dropped toothbrushes; tonic-clonic seizures, the loss of consciousness with stiffening and rhythmic jerking that everyone pictures; and atonic seizures, a sudden loss of posture with a fall.
The syndrome layer. Childhood absence epilepsy, juvenile myoclonic epilepsy, temporal lobe epilepsy with hippocampal sclerosis, frontal lobe epilepsy, and the severe epileptic encephalopathies of infancy are syndromes, and each carries its own expectations. The same tonic-clonic seizure means something different in each: in juvenile myoclonic epilepsy it usually responds well to medication but the condition is typically lifelong and is exquisitely sensitive to sleep deprivation and missed doses; in temporal lobe epilepsy with hippocampal sclerosis it often resists medication, and that combination — drug-resistant focal epilepsy with a visible lesion — is the setting in which surgery offers the best chance of lasting freedom from seizures anywhere in the condition.
How often, how much, and what it costs the day
Severity in epilepsy is not the violence of the seizure. It is read along two axes that have to be read together: what the seizures are and where they come from, and what the condition has already taken out of a life. A person with brief focal seizures several times a week can be more disabled than a person who has had one convulsion in three years.
| Axis | How it is described |
|---|---|
| Seizure type and where it begins | Focal, generalised or unknown onset, and within the focal group whether awareness is preserved or impaired and whether the seizure spreads to both hemispheres. |
| How often, and in what pattern | Per week, per month or per year, and whether they cluster — on waking, in sleep, around a menstrual cycle, or in the days after a missed dose. |
| Whether any underlying cause has been found | Structural, genetic, infectious, metabolic, immune or unknown. This axis changes both the treatment and the outlook: a lesion that can be removed, and an autoimmune encephalitis that responds to immunotherapy, are different conversations from an epilepsy with no identified cause. |
| How far treatment has been taken | Whether medication has been started, which drugs have been tried, whether each was taken at an adequate dose for long enough, and whether the failure was a true failure or a failure of dose, adherence or choice. This is the axis that decides whether epilepsy is drug-resistant, and it is the one most often unclear in a referral letter. |
| What the seizures cost in the rest of the day | Whether the person can drive, work at height or with machinery, bathe unattended, swim, care for a child alone, or hold a job without disclosure. |
| Cognition, mood and sleep | Memory, concentration, processing speed, and the depression and anxiety that occur in epilepsy at rates well above those in the general population. |
| The risks that are rare and worth naming anyway | Status epilepticus, injury during a seizure, and sudden unexpected death in epilepsy, which is rare and is associated above all with continuing tonic-clonic seizures. Naming them does not mean expecting them; it means knowing that the single measure most associated with reducing them is the same one everything else aims at, which is stopping the seizures. |
Read together, the axes do not produce a score. They answer which of three situations this is: newly diagnosed epilepsy, where the question is whether the diagnosis is right and which drug fits the seizure type; established epilepsy that is not controlled, where the question is whether two appropriate drugs have genuinely failed and whether the cause has been looked for properly; or epilepsy that is controlled, where the questions are how long treatment continues, what happens around pregnancy, and when driving and work restrictions can be revisited.
How epilepsy is established
The sequence starts with a description and proceeds to investigations that answer three separate questions: is this a seizure at all, is it epilepsy, and where does it begin. Tests are chosen to answer those in order, and an abnormal result on a test that was answering a different question is the most common source of a wrong label.
| Investigation | What it settles |
|---|---|
| The history, including an eyewitness account | Whether the event was a seizure and what kind. What the person felt at the very start, what an observer saw in the face and limbs, how long it lasted, how they were afterwards, and whether it has happened the same way before. This is the most informative part of the assessment, and a mobile phone recording of an event is worth more than a normal scan. |
| Electroencephalography | Support for the diagnosis, the classification, and the syndrome. Epileptiform activity between seizures supports epilepsy and can point to a generalised epilepsy; a normal recording does not exclude it, which is why a single normal EEG is never the end of the assessment. Sleep-deprived recordings increase the yield. |
| MRI of the brain with an epilepsy protocol | Whether there is a structural cause. The sequences and the reporting are aimed at the lesions that cause focal epilepsy — hippocampal sclerosis, malformations of cortical development, low-grade tumours, cavernous malformations, and the consequences of old injury or infection. A standard scan reported without that question in mind can miss the thing being looked for. |
| Long-term video EEG monitoring | Whether the events are seizures, where they begin, and how often they happen when nobody is counting. Used when the diagnosis is uncertain, when events are frequent and disabling, and as part of the pre-surgical evaluation. It is the study that settles the question of mimics, including the functional non-epileptic attacks that can coexist with genuine epilepsy. |
| Genetic, metabolic and immune testing, and functional imaging | Genetic and metabolic testing where the picture suggests a syndrome or a treatable metabolic condition and the result would change management. Antibody testing where the course suggests autoimmune encephalitis, because that diagnosis changes the treatment from antiseizure medication to immunotherapy. PET and ictal SPECT in the pre-surgical evaluation where the MRI is normal or does not match the electrical findings. |
A workup worth having therefore answers six things: whether the events are seizures, which type and where they begin, whether there is a structural or immune cause on imaging, what the EEG shows and under what conditions it was recorded, which drugs have been tried and at what dose for how long, and what the seizures currently prevent. The first of those is the one most often assumed rather than established, and the fifth is the one most often missing from a referral.
Why patients travel to China for epilepsy care
Epilepsy is managed in one place over years, and most of that management is outpatient and local. Travel becomes reasonable at three points: when the diagnosis itself is in doubt, because events have been called seizures without an eyewitness description or a recording and years of medication have followed; when seizures continue after two drugs and the question of surgery or stimulation has not been assessed; and when a structural or immune cause has not been looked for with imaging aimed at epilepsy.
Our neurology and neurosurgery services are organised around a standardised stroke centre built to national stroke-centre standards, and are a National Stroke Center construction unit and national GCP base. The investigations that carry the diagnosis are available in one place: long-term video EEG monitoring, alongside 3.0T MRI, dual-source CT, PET-CT and 3D DSA. Where surgery is considered, pre-surgical evaluation is conducted as a single programme rather than as a sequence of separate opinions.
The practical questions are answered the same way as for any other condition we treat. Records reviewed by a neurologist with an epilepsy interest receive a written opinion within about 48 hours of complete records arriving, and the opinion states whether the events described are seizures and which type, what the imaging and EEG show, which drugs have genuinely been tried, whether drug resistance is established and whether surgery or stimulation should be assessed, and what remains uncertain. Complete treatment in China typically runs at 30–50% of comparable care in Europe or the United States. We work with more than 30 commercial insurers for direct billing and have received patients from 124 countries and regions.